Report

Life Sciences 2030 Report

22.6.22 5 minute read

We are witnessing an evolution of the life sciences sector, both in the UK and internationally.

Not only is the sector expanding rapidly, but scientific developments are facilitating new techniques and product outputs.

The UK's quest to become a Scientific Superpower is being led by Life Sciences.

Major steps forward will be made in the coming decade, that seems certain, presenting huge opportunities for real estate investors and developers.

But the nature of scientific research is inherently uncertain. Making a deeper understanding of the sector's changing specialist requirements an essential part of Life Sciences' real estate investment.

Our Life Sciences 2030 report out today outlines how AI, robotics and specialist manufacturing will transform real estate requirements over the coming years, helping to direct development and investment into a sector on the brink of significant change.

The report explains why Biopharma, Diagnostics, Medical devices, Digital Health and Bioprocessing are our Ones to Watch in the 2020s.

And why being flexible and adaptable will help mitigate financial risk, support viability and maximise the opportunities presented by the UK’s exploding Life Sciences sector.

Download our Life Sciences 2023 report:

Enter details

Download our Life Sciences 2023 report

Download our report

Title

First name

Last name

Company

Job title

I'd like to hear more about

Offices & Labs

Yes

Science & Tech

Yes

Privacy notice

By clicking the link to download you agree to Bidwells adding your details to our database, to receive the latest news and insights. You can manage your preferences and unsubscribe here, clicking on an unsubscribe link in any email you receive from us or otherwise notifying us that you have changed your mind.

Full details of how we process personal data can be found here.

Contributors:

Max Bryan

Partner, Head of Laboratory & Office Agency

Sue Foxley

Research Director

Get in touch with our team

Sue Foxley

Research Director

Sue leads a dynamic programme of research at Bidwells. Working with her colleague Mark Callender, she is particularly focused on the real estate implications of the science and technology sector.

Max Bryan

Partner, Head of Laboratory & Office Agency

Max works with pioneering innovators and tech entrepreneurs, leading our unparalleled offices and labs agency team.

Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park

CELL & GENE THERAPY REPORT

Scientific advances with real estate implications

Cell and Gene therapies (CGT) are currently tipping the scales as the fastest growing area within the therapeutics market. Our latest report explores the evolution of CGT, market growth value, challenges, local considerations and real estate demands.

Download now

Our R&D Business Survey (2021) was undertaken with YouGov. We are also indebted to life science specialist Anil Vaidya at Ten93 for working with us on this report.

Our Expertise

Related Services

Science & Technology

Find out more

Life Sciences 2030 Report